BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 3583634)

  • 21. Full-field electroretinograms in miniature poodles with progressive rod-cone degeneration.
    Sandberg MA; Pawlyk BS; Berson EL
    Invest Ophthalmol Vis Sci; 1986 Jul; 27(7):1179-84. PubMed ID: 3721798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rod-cone interactions in night-blinding disease.
    Arden GB
    Jpn J Ophthalmol; 1987; 31(1):6-19. PubMed ID: 3498067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures.
    Roman AJ; Schwartz SB; Aleman TS; Cideciyan AV; Chico JD; Windsor EA; Gardner LM; Ying GS; Smilko EE; Maguire MG; Jacobson SG
    Exp Eye Res; 2005 Feb; 80(2):259-72. PubMed ID: 15670804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
    Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
    Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal thickness and visual thresholds measured in patients with retinitis pigmentosa.
    Apushkin MA; Fishman GA; Alexander KR; Shahidi M
    Retina; 2007 Mar; 27(3):349-57. PubMed ID: 17460591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rod and cone dysfunction in carriers of X-linked retinitis pigmentosa.
    Peachey NS; Fishman GA; Derlacki DJ; Alexander KR
    Ophthalmology; 1988 May; 95(5):677-85. PubMed ID: 3174027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cone electroretinographic change during light adaptation in retinitis pigmentosa.
    Miller S; Sandberg MA
    Invest Ophthalmol Vis Sci; 1991 Aug; 32(9):2536-41. PubMed ID: 1869408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rod electroretinograms in an elevated cyclic guanosine monophosphate-type human retinal degeneration. Comparison with retinitis pigmentosa.
    Sandberg MA; Miller S; Berson EL
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2283-7. PubMed ID: 1700774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of focal rod electroretinograms from the dark-adapted human eye.
    Sandberg MA; Pawlyk BS; Berson EL
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):930-4. PubMed ID: 8603878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pupillometric measures of retinal sensitivity in infants and adults with retinitis pigmentosa.
    Birch EE; Birch DG
    Vision Res; 1987; 27(4):499-505. PubMed ID: 3660610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease expression in X-linked retinitis pigmentosa caused by a putative null mutation in the RPGR gene.
    Jacobson SG; Buraczynska M; Milam AH; Chen C; Järvaläinen M; Fujita R; Wu W; Huang Y; Cideciyan AV; Swaroop A
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):1983-97. PubMed ID: 9331262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative relationship of the scotopic and photopic ERG to photoreceptor cell loss in light damaged rats.
    Sugawara T; Sieving PA; Bush RA
    Exp Eye Res; 2000 May; 70(5):693-705. PubMed ID: 10870528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The application of chromatic dark-adapted kinetic perimetry to retinal diseases.
    Rotenstreich Y; Fishman GA; Lindeman M; Alexander KR
    Ophthalmology; 2004 Jun; 111(6):1222-7. PubMed ID: 15177975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentric retinitis pigmentosa: clinicopathologic correlations.
    Milam AH; De Castro EB; Smith JE; Tang WX; John SK; Gorin MB; Stone EM; Aguirre GD; Jacobson SG
    Exp Eye Res; 2001 Oct; 73(4):493-508. PubMed ID: 11825021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electroretinographic findings in retinitis pigmentosa.
    Berson EL
    Jpn J Ophthalmol; 1987; 31(3):327-48. PubMed ID: 2448510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human neural retinal transplantation.
    Humayun MS; de Juan E; del Cerro M; Dagnelie G; Radner W; Sadda SR; del Cerro C
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3100-6. PubMed ID: 10967070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SWS (blue) cone hypersensitivity in a newly identified retinal degeneration.
    Jacobson SG; Marmor MF; Kemp CM; Knighton RW
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):827-38. PubMed ID: 2335450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screen of the IMPDH1 gene among patients with dominant retinitis pigmentosa and clinical features associated with the most common mutation, Asp226Asn.
    Wada Y; Sandberg MA; McGee TL; Stillberger MA; Berson EL; Dryja TP
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1735-41. PubMed ID: 15851576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Full-field ERG, multifocal ERG and multifocal VEP in patients with retinitis pigmentosa and residual central visual fields.
    Gränse L; Ponjavic V; Andréasson S
    Acta Ophthalmol Scand; 2004 Dec; 82(6):701-6. PubMed ID: 15606467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic effects of the Q64ter rhodopsin mutation in retinitis pigmentosa.
    Milam AH; Li ZY; Cideciyan AV; Jacobson SG
    Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):753-65. PubMed ID: 8603860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.